Purchase of own shares

In line with the Company’s announcement on 7 March 2018, the Company would consider returning further cash to shareholders by way of share buybacks during the course of 2018 in lieu of paying a dividend.

The Company announces that on 23 April 2018 it purchased 127,602 of its ordinary shares on the London Stock Exchange at a price of 289.4353 pence per share.  The purchased shares will be cancelled.

Aggregated information:


Date of purchase:

23 April 2018

Number of ordinary shares purchased:


Volume weighted average price paid per share:

289.4353 pence



Transaction details:


Issuer name:

Bioquell Plc








Total Number of Voting Rights

In accordance with DTR 5.6.1 of the FCA’s Disclosure Guidance and Transparency Rules, the Company is required to notify the market of the total number of voting rights and capital in the Company as at the end of each calendar month in which an increase or decrease has occurred.

The issued share capital of the Company is comprised of 23,192,249 ordinary shares of 10p each.  As 797,000 of these ordinary shares are held as treasury shares, the total number of voting rights in the Company is 22,395,249.  This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.



Bioquell PLC

Tel: +44 (0)1264 835800


Ian Johnson,  Executive Chairman



Michael Roller, Finance Director





N+1 Singer

Tel: +44 (0) 20 7496 3000


Mark Taylor / James White